| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.51 M USD | -3.29 M USD | -6.17 M USD | -10.23 M USD | -9.55 M USD | -9.03 M USD | -10.34 M USD | -9.61 M USD | -6.15 M USD | -3.20 M USD |
| Depreciation & Amortization | 859354 USD | 205910 USD | 164306 USD | 192799 USD | 145995 USD | 105382 USD | 95124 USD | 69682 USD | 11415 USD | 7731 USD |
| Stock-Based Compensation | 2.08 M USD | 874438 USD | 1.12 M USD | 1.19 M USD | 1.10 M USD | 614302 USD | 907993 USD | 814666 USD | 279508 USD | 94094 USD |
| Capital Expenditures | 1.74 M USD | 1.36 M USD | 145816 USD | 111793 USD | 326462 USD | 45752 USD | 51991 USD | 126867 USD | 67002 USD | 1865 USD |
| Cash Flow from Investing | -7.06 M USD | 259981 USD | -2.03 M USD | -310793 USD | -326462 USD | -45752 USD | -51991 USD | -126867 USD | -67002 USD | -1865 USD |
| Cash Flow from Financing | 11.43 M USD | 20.93 M USD | 9.71 M USD | 376858 USD | 13.17 M USD | 16.78 M USD | 8.32 M USD | 3.34 M USD | 18.38 M USD | 2.96 M USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | -16.25 M USD | -4.65 M USD | -6.32 M USD | -10.35 M USD | -9.87 M USD | -9.08 M USD | -10.39 M USD | -9.73 M USD | -6.22 M USD | -3.20 M USD |
Myomo Inc. is a pioneering company in the field of medical robotics, specializing in the development and production of powered brace systems, specifically for upper-extremity mobility enhancement. These orthotic devices, branded under the name MyoPro, are designed to assist individuals dealing with neuromuscular malfunctions such as those caused by stroke, brachial plexus injury, or other neurological conditions. The primary function of MyoPro is to help users restore functionality and independence in their arms through advanced sensor technology that detects and amplifies the user's own muscle signals. Operating at the intersection of healthcare and technology, Myomo Inc. serves a vital role in the rehabilitation industry, transforming the lives of patients who previously had limited options for recovery. By providing a non-invasive solution to regain strength and mobility, the company's products are significant in addressing a growing need within the healthcare market. Myomo's innovative approach to patient care positions it as an influential player in the medical device sector, contributing to advancements in prosthetics and orthotics.